Optimising infliximab treatment in inflammatory bowel disease

Category Primary study
JournalEuropean Journal of Hospital Pharmacy
Year 2015
This article has no abstract
Epistemonikos ID: 520ab8353dc31d299507279eedbbfbe63577339c
First added on: Feb 08, 2025